Suboxone is the brand name for buprenorphine combined with naloxone, taken as a sublingual film or tablet for opioid use disorder. Pricing it means pricing two things people often conflate: the medication, which went generic years ago and is cheap, and the ongoing clinical relationship required to keep the prescription coming, which is usually the larger number.
This guide separates them. It prices the generic film and tablet, brand Suboxone, and the extended-release injectables Sublocade and Vivitrol, then covers the prescriber, opioid treatment program billing, and where federal grant money already pays the bill. All figures verified September 2, 2026.
What Does Suboxone Cost Without Insurance?
Three sources anchor the table. CMS publishes the National Average Drug Acquisition Cost, what pharmacies actually pay wholesale, updated weekly. SingleCare publishes live retail and card prices, updated September 2, 2026. Indivior and Alkermes publish list prices for their own injectables.
| Product | Low (monthly) | Typical (monthly) | High (monthly) |
|---|---|---|---|
| Generic buprenorphine-naloxone 8/2 mg tablet, 30 | $19.14 | $25.00 | $60.00 |
| Generic buprenorphine-naloxone 8/2 mg film, 30 | $35.59 | $62.23 | $194.06 |
| Brand Suboxone 8/2 mg film, 30 | $257.83 | $429.00 | $429.00 |
| Zubsolv 8.6/2.1 mg tablet, 30 (wholesale) | $474.41 | $474.41 | $474.41 |
| Sublocade injection (list price) | $2,202.03 | $2,202.03 | $2,202.03 |
| Vivitrol 380 mg injection (wholesale) | $1,716.48 | $1,716.48 | $1,716.48 |
| Prescriber, cash telehealth program | $150.00 | $249.00 | $300.00 |
| Medicare OTP weekly bundle, oral buprenorphine | $296.57/wk | $296.57/wk | $296.57/wk |
The largest cost decision here is generic versus brand, and it is not close. In CMS data effective August 19, 2026, brand Suboxone 8 mg/2 mg film costs pharmacies $8.59422 per film while the identical-strength generic is $2.07434. Over 30 days that is $257.83 versus $62.23 in wholesale cost alone. SingleCare’s May 2026 analysis puts the retail versions at $429 for brand against $49 for the generic with its card.
The second largest is film versus tablet, which almost nobody thinks to ask about. The generic 8 mg/2 mg tablet is $0.63786 per dose in the same CMS data, so 30 tablets cost pharmacies $19.14 against $62.23 for 30 films. Workit Health’s price guide found the same pattern at retail: about $25 for 14 tablets against $36 for 14 films at the cheapest pharmacies it checked.
Pharmacy spread on the generic
SingleCare’s page updated September 2, 2026 shows an average retail cash price of $194.06 for a box of 8 mg/2 mg sublingual film and a card price of $35.59, with per-pharmacy card prices of $35.59 at CVS, $43.83 at Kroger and Harris Teeter, $44.40 at Food Lion, $47.04 at Publix and $56.23 at Costco. The card closes a gap of roughly $158 on the same product.
Workit Health also notes a quantity effect: it found film prices roughly $0.50 per strip lower in 60-count packages than in 14-count. Because buprenorphine is a controlled substance a prescriber cannot write extra doses purely to get you a better unit price, but if your dose supports a 60-count fill, that is a legitimate conversation.
The Prescriber Is Usually the Bigger Bill
The medication is the cheap part. Whoever writes it is not.
Cash telehealth programs. Bicycle Health posts a flat self-pay rate of $249 a month covering as many visits as your treatment plan calls for, unlimited messaging, care navigation and support groups, with labs at $0 and the prescription listed separately at $0 to $150. On the same page it puts an in-person clinic at $250 or more per visit with $78 labs.
Opioid treatment programs. OTPs are the licensed clinics that dispense methadone and buprenorphine on site. Medicare pays them a bundled weekly rate, and the CY 2026 rates published by CMS benchmark what that bundle is worth: $296.57 a week for oral buprenorphine ($63.69 of drug plus $232.88 of counseling, therapy and toxicology testing), $277.29 for methadone, and $220.34 with no drug. Intake is a separate $234.59.
Those are Medicare payment rates, not cash prices, but they show what a full-service program costs to run: roughly $1,186 a month. Cash-pay quotes from OTPs generally land below that because they are not delivering every service in the bundle.
Any DEA-registered prescriber. Section 1262 of the Consolidated Appropriations Act, 2023 eliminated the DATA-waiver, better known as the X-waiver, along with the 30, 100 and 275 patient caps attached to it. Per SAMHSA, all practitioners with a current DEA registration that includes Schedule III authority may now prescribe buprenorphine for opioid use disorder if state law permits. SAMHSA decommissioned its Behavioral Waiver Notification System on June 1, 2026 because there is nothing left to notify. Practically, a primary care doctor, nurse practitioner or physician assistant at a regular clinic can prescribe this, and an ordinary office visit is often far cheaper than a program fee.
Telehealth Rules As They Stand in 2026
Telehealth prescribing is legal and widely used, and the rule underpinning it has a date on it.
On December 31, 2025, DEA and HHS jointly published a fourth temporary extension of COVID-19 telemedicine flexibilities, effective January 1, 2026, allowing DEA-registered practitioners to prescribe Schedule II-V controlled medications without a prior in-person medical evaluation through December 31, 2026.
Separately, the final rule Expansion of Buprenorphine Treatment via Telemedicine Encounter, published January 17, 2025, lets a practitioner who reviews the patient’s state prescription drug monitoring program data during the encounter prescribe an initial six-month supply through audio-only telemedicine, with later prescriptions issued under other telemedicine authorities or after an in-person evaluation. It also requires the pharmacist to verify the patient’s identity before filling.
Both matter for cost because they are what make a $150 to $250 flat-fee national telehealth program possible instead of a local clinic with a facility fee. If the flexibilities are not extended past December 31, 2026, that market changes.
What Drives the Price
Brand versus generic. A roughly seven-to-one wholesale gap, and the single biggest lever available to you.
Film versus tablet. A roughly three-to-one wholesale gap on the generic, and one most people never raise with their prescriber.
Whether you use a discount card. $35.59 with a card against $194.06 average retail on the same generic, per SingleCare’s September 2026 data.
Dispensed versus prescribed. An OTP that dispenses on site bundles the drug into a program fee. A prescription you fill at a retail pharmacy separates the two, which usually costs less in total.
Oral versus extended-release injection. Sublocade lists at $2,202.03 a month and Vivitrol costs $1,716.48 per vial wholesale, against $19 to $62 for a month of generic oral buprenorphine-naloxone. Not clinically interchangeable, but the gap is 30 to 100 times.
Sublocade: The Monthly Injection
Sublocade is extended-release buprenorphine injected under the skin monthly by a provider. Indivior states on its own savings page that the list price for both the 100 mg and 300 mg doses is $2,202.03 per month, accurate as of January 1, 2026, and that an uninsured patient “can expect to pay the list price.”
The company runs a copay assistance program under which it says 95% of enrolled patients pay $0, but that program is limited to patients with private insurance and excludes anyone with Medicare, Medicaid, VA, DOD, TRICARE or CHAMPVA coverage. For an uninsured cash payer the copay card is not the answer; Indivior’s INSUPPORT line is what it points to instead.
Medicare’s OTP bundle gives another read on the drug’s real cost. Code G2069, the monthly injectable buprenorphine bundle, is paid at $2,063.77 in CY 2026, of which $1,823.20 is the drug. The weekly injectable bundle, code G0533, is $637.40 with $396.83 of drug.
Vivitrol: The Naltrexone Alternative
Vivitrol is extended-release naltrexone, a full opioid blocker rather than a partial agonist. In CMS NADAC data effective August 19, 2026, a 380 mg vial with diluent costs $1,716.48. Medicare’s weekly naltrexone OTP bundle, code G2073, is $1,760.73 with $1,520.16 of that being drug cost.
Oral naltrexone is a different story. The 50 mg tablet costs pharmacies $1.13919 in the same data, or $34.18 for 30 days, roughly 50 times less than the injection. It requires daily adherence, which is precisely what the injection is designed to remove.
Alkermes runs a Vivitrol copay savings program under which eligible patients “may pay as little as $0,” capped at $500 per prescription, 12 prescriptions a year and $6,000 a year total. Like Indivior’s, it excludes anyone in a government program that pays any portion of medication costs, and it does not help with the office visit or administration fee.
Cash Price vs. Insurance
For generic buprenorphine-naloxone, cash frequently wins. A $35.59 card price is at or below most generic copays and it skips prior authorization, which insurers still apply to this drug class in many plans. Cash prices do not count toward a deductible, but on a $36 monthly fill that rarely changes the math.
For Sublocade and Vivitrol the arithmetic inverts. At $2,202.03 and $1,716.48, no cash payer should be paying list. If either has been recommended and you are uninsured, the coverage question comes before the price question.
Our fair price checker is a quick sanity check on any quote, and our comparison of GoodRx vs. SingleCare covers how to check card prices in two minutes.
How to Pay Less
-
Ask specifically for generic buprenorphine-naloxone, and ask whether the tablet works for you. Brand to generic is roughly a seven-to-one saving; film to tablet is roughly three-to-one on top of that.
-
Run a discount card at three pharmacies before your first fill. SingleCare’s September 2026 data spans $35.59 to $56.23 on card prices for the same generic, against $194.06 average retail.
-
Use a federally qualified health center or free clinic for the prescribing. Any DEA-registered practitioner with Schedule III authority can now write this, so the prescriber does not have to be a specialty program. FQHCs and free clinics charge on an income-based sliding scale. See our guide to free and sliding-scale clinics.
-
Ask your state about State Opioid Response funding. SAMHSA allocated more than $1.48 billion in FY25 State Opioid Response grants plus nearly $63 million in Tribal Opioid Response grants, and reports more than 650,000 people have received medications for opioid use disorder through the program since 2018. That money is spent locally and often covers medication and visits for uninsured patients outright.
-
Price the telehealth flat fee against a local clinic visit. A posted $249 a month covering unlimited visits, messaging and labs can beat paying per visit somewhere that also charges $78 for labs, or lose badly if you need one short visit a month. Our doctor visit cost guide covers what an office visit runs cash.
-
Do not accept list price on an injectable without calling the manufacturer first. Indivior and Alkermes both run patient support lines separate from their copay cards, and the cards themselves are useless to the uninsured and to anyone on a government plan.
-
Dispute any facility fee on a prescription visit. Hospital-owned clinics add facility fees to what looks like a simple medication management appointment. Our guide to negotiating medical bills covers how to push back.
Bottom Line
If you are on generic buprenorphine-naloxone, your medication should cost roughly $36 to $62 a month with a discount card, and closer to $20 if the tablet works for you. Paying $429 a month for brand Suboxone film means you are buying a name, not a different drug.
The prescriber is the part to shop. It runs from a sliding-scale FQHC visit to a $249 monthly telehealth subscription to a full OTP bundle worth roughly $1,186 a month at Medicare rates, and any DEA-registered prescriber can now write it.
For the injectables, the number that matters is coverage, not price. At $1,716 to $2,202 a month, Sublocade and Vivitrol are not cash purchases for almost anyone, and the conversation should start with what your state’s opioid response funding and Medicaid eligibility can do.
If you or someone around you also needs overdose reversal medication, see our Narcan cost guide. For related pricing, see our therapy cost guide and our antidepressant cost guide.